Skip to search formSkip to main contentSkip to account menu

CAPOX-Bevacizumab Regimen

Known as: CAPOX-Avastin Regimen, Capecitabine-Oxaliplatin-Bevacizumab Regimen 
A chemoimmunotherapy regimen consisting of capecitabine, oxaliplatin and bevacizumab used as an initial treatment for advanced-stage or metastatic… 
National Institutes of Health

Related topics

Related topics

4 relations
Colorectal Carcinomabevacizumabcapecitabineoxaliplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Pre- versus postoperative CAPOX plus bevacizumab (CAPOX-Bev) for resectable liver metastases from colorectal cancer (CLM): A randomized phase II/III trial (HiSCO-01).
4021Background: The role of neoadjuvant chemotherapy, particularly for those with initially resectable CLM, is controversial. And… 
2020
2020
[Perioperative Chemotherapies for Patients with Colorectal Liver Metastasis].
Perioperative chemotherapies are expected to improve prognosis of patients with colorectal liver metastasis(CRLM). In patients… 
2013
2013
Dosimetric predictors of gastrointestinal toxicity during IMRT-CAPOX in rectal cancer
2012
2012
Prospective Phase I Study of Capecitabine and Oxaliplatin Concurrent with Radiation Therapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma, and Retrospective Comparison to Concurrent…
PurposeThe aims of this study is to determine the maximum tolerated dose of capecitabine and oxaliplatin (CAPOX) delivered… 
2012
2012
Cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative triple treatment for rectal cancer (CET-CAPOX-RT-Phase-I/II Study): Influence on long-term survival and relevance of biomarkers.
e14162 Background: Preoperative application of cetuximab and radiochemotherapy combined with 5-FU+oxaliplatin (CET-CAPOX-RT-phase… 
2011
2011
Preoperative chemoradiation (CRT) with concurrent capecitabine (Cap), oxaliplatin (Ox), and bevacizumab (Bev) in patients with locally advanced rectal cancer (RC): Effects on pathological complete…
3630 Background: Preoperative CRT is the standard of care for patients with locally advanced RC (stage II and III). Pathological… 
2011
2011
Effect of pathohistologic complete remission (pCR) rate on the prediction of long-term prognosis following chemoradiotherapy (XRT) with cetuximab (Cet), capecitabine (CAP), and oxaliplatin (OX; Cet…
e14035 Background: Preoperative XRT with Cet, CAP and OX (Cet-CAPOX) simultaneously to 50.4 Gy in fractions of 1.8 Gy has shown… 
2010
2010
Análise da expressão do gene CaPox que codifica uma peroxidase de classe III envolvida na interação do cafeeiro com nematóides
2007
2007
Cetuximab, capecitabine, and oxaliplatin (Cet-CapOx) with concurrent radiotherapy (RT) in advanced rectal cancer (RC): Results of a phase I/II trial
4042 Background: CapOx given concurrently with neoadjuvant RT in rectal cancer is well tolerated and has achieved high rates of… 
2007
2007
3000 ORAL Randomised phase III study of capecitabine, oxaliplatin and bevacizumab (CAPOX-B) with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)